 |
|
Comments - Posted 15 May 2008
Read remarks by Dave Morgan about
Bayer AJ et al.
NEWS: AD Immunotherapy: Toward Prevention, DNA-based Vaccines?
Comments - Posted 15 May 2008
Read remarks by Valerie Cullen about Mata IF et al.
PAPER: Glucocerebrosidase gene mutations: a risk factor for lewy body disorders.
Comments - Posted 15 May 2008
Read remarks by Kevin Barnham about Barnham KJ et al.
PAPER: Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease.
Job - Posted 15 May 2008
Research Scientists: Columbia University, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, New York, NY.
Comments - Posted 14 May 2008
Read remarks by Corinne Augelli-Szafran about
Barnham KJ et al.
NEWS: More Precious Than Gold? Platinum Inhibitors Target Aβ
Comments - Posted 14 May 2008
Read remarks by Gordon Wilcock about Wilcock GK et al.
PAPER: Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Comments - Posted 14 May 2008
Read remarks by Emory Hill
Alzforum: News: AD Vaccine
Comments - Posted 14 May 2008
Read remarks by M. Paul Murphy
Alzforum: News: AD Vaccine
Comments - Posted 13 May 2008
Read remarks by Boris Schmidt about Barnham KJ et al.
PAPER: Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease.
Comments - Posted 13 May 2008
Read remarks by Kevin Barnham about Barnham KJ et al.
PAPER: Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease.
Comments - Posted 13 May 2008
Read remarks by Terrence Town about Movsesyan N et al.
PAPER: Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.
Comments - Posted 13 May 2008
Read remarks by William Klunk about Movsesyan N et al.
PAPER: Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.
Comments - Posted 13 May 2008
Read remarks by Roger N. Rosenberg about Movsesyan N et al.
PAPER: Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.
Comments - Posted 13 May 2008
Read remarks by Claudia Bagni about Hébert SS et al.
PAPER: Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression.
Comments - Posted 12 May 2008
Read remarks by Thomas Willnow about
Muhammad A et al.
NEWS: Mice, Flies Further Implicate Retromer in Pathogenesis
Comments - Posted 12 May 2008
Read remarks by Giuseppina Tesco about
Muhammad A et al.
NEWS: Mice, Flies Further Implicate Retromer in Pathogenesis
Grants Update - Posted 10 May 2008
Program: Mouse Models Containing Human Alleles: Novel Tools to Study Brain Function (R21/R33)
Funds: R21 Phase: $200K over 2yrs; R33 Phase: $150K for 1yr. See program for details.
Deadline(s): Letters of Intent Receipt Date(s): 30 days prior to application receipt date; Application deadlines: June 26, 2008; January 28, 2009; May 28, 2009; January 28, 2010; May 28, 2010; January 28, 2011
Comments - Posted 9 May 2008
Read remarks by Austin Yang about Barnham KJ et al.
PAPER: Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease.
Job - Posted 9 May 2008
Postdoctoral Fellow: Oregon Health & Science University, Portland, Oregon.
|
|
|
|
|
|
Home
